Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatic enzymes and function abnormalities
ADR ID BADD_A02000
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.02      Hepatic enzymes and function abnormalities
Description Not Available
MedDRA Code 10019661
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00168Arsenic--
BADD_D00169Arsenic trioxide0.000112%
BADD_D00175Asparaginase--
BADD_D00176Atazanavir--
BADD_D00177Atazanavir sulfate--
BADD_D00179Atezolizumab--
BADD_D00180Atomoxetine0.000232%
BADD_D00193Axitinib0.001220%
BADD_D00194Azacitidine0.000112%
BADD_D00195Azathioprine0.001786%
BADD_D00203Azithromycin--
BADD_D00204Azithromycin dihydrate--
BADD_D00205Azithromycin monohydrate--
BADD_D00206Aztreonam0.000122%
BADD_D00209Baclofen--
BADD_D00210Balsalazide--
BADD_D00214Basiliximab--
BADD_D00221Bedaquiline--
BADD_D00225Belinostat--
BADD_D00230Bendamustine0.000224%
BADD_D00269Bexarotene0.000112%
BADD_D00271Bicalutamide0.018279%
BADD_D00277Bisoprolol0.002355%
BADD_D00282Blinatumomab--
BADD_D00284Bortezomib--
BADD_D00285Bosentan--
BADD_D00286Bosutinib0.000996%
BADD_D00287Bosutinib monohydrate--
BADD_D00289Botulinum neurotoxin a/b immune globulin (human)--
BADD_D00293Brexpiprazole0.000418%
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 19 Pages
ADReCS-Target
ADR Term Drug Name Target